News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s basic science academic departments. The links below take you to articles where you can learn more about our faculty’s latest achievements.
Want more news? Sign up to our quarterly newsletter, Back to Basic, and be sure to connect with us on social media. Find us on Bluesky, LinkedIn and X.
To share your news, please take a moment to complete this form.
Biochemistry and Molecular Genetics
- 06.09.2025
Feng Yue, PhD, the Duane and Susan Burnham Professor of Molecular Medicine in the Department of Biochemistry and Molecular Genetics, has been inducted into the 2025 class of American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
- 05.30.2025
Genetic makeup and structure can shift dramatically across different areas of a single glioblastoma tumor, reveals a Northwestern Medicine study published in Science Advances.
- 05.08.2025
Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and respond to disease and acute inflammation, findings that may inform the development of targeted therapies for cancer and tissue injury, according to a recent study published in the Journal of Clinical Investigation.
Cell and Developmental Biology
- 06.24.2025
Northwestern Medicine scientists have discovered a previously unknown process used by epithelial cells to alleviate epithelial tissue crowding and avoid cell damage and loss, according to a recent study published in Nature Communications.
- 04.28.2025
Northwestern Medicine scientists have shed new light on the inner workings of some of the finest filament cellular structures, according to a study published in the Journal of Cell Biology.
- 04.16.2025
Scientists have uncovered new details about cellular filaments that play a critical role in wound healing, according to a study published in the Proceedings of the National Academy of Sciences.
Microbiology-Immunology
- 06.10.2025
Every year at Feinberg, a handful of start-up companies are born from discoveries in the lab. Paperwork is filed for hundreds of inventions and patents; patents are issued and the process for optioning and licensing technology through Northwestern’s Innovations and New Ventures Office (INVO) can be the launching point for scientists to bring their research to commercialization.
- 06.02.2025
Northwestern Medicine scientists have uncovered new details about how poxvirus hijacks its host’s protein synthesis machinery to multiply and spread, according to a study published in Nature Microbiology.
- 05.12.2025
A new Northwestern study may explain why the body may continue to respond to an invisible threat long after bacterial death in Lyme disease.
Pharmacology
- 04.30.2025
A new Northwestern Medicine study has identified the molecular mechanisms that cause a commonly prescribed antipsychotic drug to produce harmful side effects similar to Parkinson’s disease symptoms, according to findings published in Molecular Psychiatry.
- 04.10.2025
Scientists have developed a novel, robust proteomics technique that can more accurately identify and spatially characterize thousands of proteins in single cells within human tissue samples, as detailed in a recent study published in Nature Communications.
- 03.25.2025
Investigators from Northwestern University Feinberg School of Medicine and Vanderbilt University School of Medicine have discovered new molecular mechanisms behind a genetic heart disorder that can increase the risk of sudden death in children and young adults, according to a recent study published in PNAS.
Neuroscience
- 04.30.2025
A new Northwestern Medicine study has identified the molecular mechanisms that cause a commonly prescribed antipsychotic drug to produce harmful side effects similar to Parkinson’s disease symptoms, according to findings published in Molecular Psychiatry.
- 04.03.2025
D. James Surmeier, PhD, was awarded a two-year grant from Spark NS for the development of a calcium channel inhibitor to slow Parkinson’s Disease progression. This is one of only eight projects and principal investigators selected for the SPARK NS Translational Research Program 2025 Cohort. Participation in a SPARK NS program cohort lasts two years and includes milestone-based funding of up to $2,000,0001 for each project, education and training in drug development and translational research for participating teams, mentoring from 75+ industry expert advisors, and scientific and business networking opportunities.
- 12.20.2024
From probing the human brain to elucidating mechanisms behind cellular responses, Feinberg investigators have provided stunning new snapshots of biological processes invisible to the naked eye.